Similarly, a decrease in activated Th1 cells and improvements in arthritis and skin lesions were observed in activated Th1-dominant patients treated with IL-12/23(p40)-i, while a decrease in activated Th1/Th17 cells and improvement in arthritis and skin lesions were observed in Th1/Th17-high patients who received TNF-i. Here, TNF is linked to Arthritis.